Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997)

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 998-1003

  Fang, Z ^a,c   Doig, C ^b   Rayner, A ^b   Kenna, D T ^a   Watt, B ^b   Forbes, K J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL DNA; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; SPARFLOXACIN;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EVOLUTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED KINGDOM;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0033065965     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.998-1003.1999     Document Type: Article

References (41)

1. Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W. Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N. Engl. J. Med. 330:1710-1716.
2. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 2633:227-230.
3. Beck-Sague, C., S. W. Dooley, M. D. Hutton, J. Otten, A. Breeden, J. T. Crawford, A. E. Pitchenik, C. Woodley, G. Cauthen, and W. R. Jarvis. 1992. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 268: 1280-1286.
4. Bifani, P. J., B. B. Plikaytis, V. Kapur, K. Stockbauer, X. Pan, M. L. Lutfey, S. L. Moghazeh, W. Eisner, T. M. Daniel, M. H. Kaplan, J. T. Crawford, J. M. Musser, and B. N. Kreiswirth. 1996. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275:452-457.
5. Bloch, A. B., G. M. Cauthen, I. M. Onorato, K. G. Dansbury, G. D. Kelly, C. R. Driver, and D. E. Snider, Jr. 1994. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271:665-671.
6. Bodmer, T., G. Zurcher, P. Imboden, and A. Telenti. 1995. Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 35:345-348.
7. Deretic, V., W. Philipp, S. Dhandayuthapani, M. H. Mudd, R. Curcic, T. Garbe, B. Heym, L. E. Via, and S. T. Cole. 1995. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol. Microbiol. 17:889-900.
8. Dice, L. R. 1945. Measures of amount of ecological association between species. Ecology 26:297-302.
9. Dobner, P., S. Rusch-Gerdes, G. Bretzel, K. Feldmann, M. Rifai, T. Loscher, and H. Rinder. 1997. Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 1:365-369.
10. el Baghdadi, J., R. Lazraq, S. Ibrahimy, Z. Bouayad, R. Guinet, and A. Benslimane. 1997. Survey of primary drug resistance of Mycobacterium tuberculosis in Casablanca, Morocco. Int. J. Tuberc. Lung Dis. 1:309-313.
11. Fang, Z., N. Morrison, B. Watt, C. Doig, and K. J. Forbes. 1998. IS6110 transposition and evolutionary scenario of the direct repeat locus in a group of closely related Mycobacterium tuberculosis strains. J. Bacteriol. 180:2102-2109.
12. Farr, B. M. 1994. Rifamycins, p. 317-328. In G. L. Mandell, J. Douglas, and J. E. Bennett (ed.), Principles and practices of infectious diseases, 4th ed. Churchill Livingstone, Inc., New York, N.Y.
13. Frieden, T. R., L. F. Sherman, K. L. Maw, P. I. Fujiwara, J. T. Crawford, B. Nivin, V. Sharp, D. Hewlett, Jr., K. Brudney, D. Alland, and B. N. Kreisworth. 1996. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276:1229-1235.
14. Fujiwara, P. I., and L. F. Sherman. 1997. Multidrug-resistant tuberculosis: many paths, same truth. Int. J. Tuberc. Lung Dis. 1:297-298.
15. Gordin, F. M., E. T. Nelson, J. P. Matts, D. L. Cohn, J. Ernst, D. Benator, C. L. Besch, L. R. Crane, J. H. Sampson, P. S. Bragg, and W. El-Sadr. 1996. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 154:1478-1483.
16. Goyal, M., L. P. Ormerod, and R. J. Shaw. 1994. Epidemiology of an outbreak of drug-resistant tuberculosis in the U.K. using restriction fragment length polymorphism. Clin. Sci. 86:749-751.
17. Heifets, L. B., and M. D. Iseman. 1985. Determination of in vitro susceptibility of mycobacteria to ansamycin. Am. Rev. Respir. Dis. 132:710-711.
18. Heym, B., E. Stavropoulos, N. Honore, P. Domenech, B. Saint-Joanis, T. M. Wilson, D. M. Collins, M. J. Colston, and S. T. Cole. 1997. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect. Immun. 65: 1395-1401.
19. Kim, S. J., G. H. Bai, and Y. P. Hong. 1997. Drug-resistant tuberculosis in Korea, 1994. Int. J. Tuberc. Lung Dis. 1:302-308.
20. Leen, C. Personal communication.
21. Leitch, A. G., M. Rubilar, B. Watt, R. Laing, L. Willcocks, R. P. Brettle, and C. L. Leen. 1995. Why disease due to Mycobacterium tuberculosis is less common than expected in HIV-positive patients in Edinburgh. Respir. Med. 89:495-497.
22. Lynch, A. S., and E. C. C. Lin. 1996. Responses to molecular oxygen, p. 1526-1538. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
23. Miller, L. P., J. T. Crawford, and T. M. Shinnick. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
24. Moss, A. R., D. Alland, E. Telzak, D. Hewlett, Jr., V. Sharp, P. Chiliade, V. LaBombardi, D. Kabus, B. Hanna, L. Palumbo, K. Brudney, A. Weltman, K. Stoeckle, K. Chirgwin, M. Simberkoff, S. Moghazeh, W. Eisner, M. Lutfey, and B. Kreiswirth. 1997. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int. J. Tuberc. Lung Dis. 1:115-121.
25. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514. (Review.)
26. Needleman, S. B., and C. D. Wunsch. 1970. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48:443-453.
27. Niemann, S., S. Rusch-Gerdes, and E. Richter. 1997. IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995. J. Clin. Microbiol. 35:3015-3020.
28. Rigouts, L., M. Kubin, M. Havelkova, and F. Portaels. 1994. DNA fingerprint analysis of drug resistant Mycobacterium tuberculosis strains isolated in the Czech Republic. Cent. Eur. J. Public Health 2:58-59.
29. Rouse, D. A., J. A. DeVito, Z. Li, H, Byer, and S. L. Morris. 1996. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol. Microbiol. 22: 583-592.
30. Scottish Centre for Infection and Environmental Health. 1995. Tuberculosis. Scottish Centre for Infection and Environmental Health Weekly Report 29(95/43):1.
31. Sesin, G. P., S. F. Manzi, and R. Pacheco. 1996. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection. Am. J. Health Syst. Pharm. 53:2585-2590. (Review.) (Erratum, 54:442, 1997.)
32. Sherman, D. R., K. Mdluli, M. J. Hickey, T. M. Arain, S. L. Morris, C. E. Barry, and C. K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
33. Siddiqi, S. 1989. Bactect TB systems: product and procedure manual. Becton Dickinson and Co., Paramus, N.J.
34. Smith, T. F., and M. S. Waterman. 1981. Comparison of biosequences. Adv. Appl. Math. 2:482-489.
35. Snider, J. 1994. Global burden of tuberculosis, p. 3-59. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
36. Sreevatsan, S., X. Pan, Y. Zhang, V. Deretic, and J. M. Musser. 1997. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 41: 600-606.
37. van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, and T. M. Shinnick. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31: 406-409.
38. Victor, T. C., R. Warren, J. L. Butt, A. M. Jordaan, J. V. Felix, A. Venter, F. A. Sirgel, H. S. Schaaf, P. R. Donald, M. Richardson, M. H. Cynamon, and P. D. van Helden. 1997. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J. Med. Microbiol. 44:847-857.
39. Weyer, K., and H. H. Kleeberg. 1992. Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement. Tuberc. Lung Dis. 73:106-112.
40. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
41. Zhang, Y., S. Dhandayuthapani, and V. Deretic. 1996. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc. Natl. Acad. Sci. USA 93:13212-13216.